Kiadis Pharma N.V. – LSE:0RBP.L

Kiadis Pharma N.V. stock price today

EUR 5.45

Kiadis Pharma N.V. stock price monthly change

+0.83%
month

Kiadis Pharma N.V. stock price quarterly change

+3.32%
quarter

Kiadis Pharma N.V. key metrics

Market Cap
 1
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 N/A
Income
 N/A
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Kiadis Pharma N.V. stock price history

Kiadis Pharma N.V. stock forecast

Kiadis Pharma N.V. financial statements

Kiadis Pharma N.V. other data

Frequently Asked Questions (FAQ)

  • What's the price of Kiadis Pharma N.V. stock today?

    One share of Kiadis Pharma N.V. stock can currently be purchased for approximately $5.45.

  • When is Kiadis Pharma N.V.'s next earnings date?

    Unfortunately, Kiadis Pharma N.V.'s (0RBP.L) next earnings date is currently unknown.

  • Does Kiadis Pharma N.V. pay dividends?

    No, Kiadis Pharma N.V. does not pay dividends.

  • How much money does Kiadis Pharma N.V. make?

    Kiadis Pharma N.V. has a market capitalization of 1.

  • What is Kiadis Pharma N.V.'s stock symbol?

    Kiadis Pharma N.V. is traded on the LSE under the ticker symbol "0RBP.L".

  • What is Kiadis Pharma N.V.'s primary industry?

    Company operates in the Biotechnology sector and Pharmaceuticals, Biotechnology & Life Sciences industry.

  • How do i buy shares of Kiadis Pharma N.V.?

    Shares of Kiadis Pharma N.V. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Kiadis Pharma N.V. have?

    Kiadis Pharma N.V. employs 103 workers.

  • When Kiadis Pharma N.V. went public?

    Kiadis Pharma N.V. is publicly traded company for more then 10 years since IPO on 2 Jul 2015.

  • What is Kiadis Pharma N.V.'s official website?

    The official website for Kiadis Pharma N.V. is kiadis.com.

  • Where are Kiadis Pharma N.V.'s headquarters?

    Kiadis Pharma N.V. is headquartered at Paasheuvelweg 25A, Amsterdam, NOORD-HOLLAND.

  • How can i contact Kiadis Pharma N.V.?

    Kiadis Pharma N.V.'s mailing address is Paasheuvelweg 25A, Amsterdam, NOORD-HOLLAND and company can be reached via phone at +31 20 240 5250.

Kiadis Pharma N.V. company profile:

Kiadis Pharma N.V.

kiadis.com
Exchange:

LSE

Full time employees:

103

Industry:

Pharmaceuticals, Biotechnology & Life Sciences

Sector:

Biotechnology

Kiadis Pharma N.V., a biopharmaceutical company, develops cell-based immunotherapy products in the field of blood building system. The company develops K-NK002 as an adjunctive immunotherapeutic, which is in Phase II clinical trials for blood cancer patients undergoing a haploidentical HSCT with the post-transplant cyclophosphamide (PTCy) protocol; and K-NK003, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia relapse/refractory (AML R/R). The company's preclinical stage product include K-NK00X, a NK-cell therapy candidate for the treatment of various solid tumors. It has a collaboration agreement with Harbour BioMed, Utrecht University, Erasmus Medical Center, and Viroclinics-DDL for the development of a combination of a monoclonal antibody and natural killer cells as a treatment for COVID-19. Kiadis Pharma N.V. was founded in 1997 and is headquartered in Amsterdam, the Netherlands.

+31 20 240 5250
Paasheuvelweg 25A
Amsterdam, NOORD-HOLLAND

:
ISIN: NL0011323407
CUSIP: N4855A100